申请人:The Procter & Gamble Company
公开号:US04544669A1
公开(公告)日:1985-10-01
Alkadienamide compounds, and pharmaceutically-acceptable salts thereof, of the formula: ##STR1## wherein X is O or S; R is straight or branched diene having from 11 to 23 carbon atoms; R.sub.1 is H, OH, or OCH.sub.3 ; R.sub.2 is OH or a short-chain ester; and wherein at least one of R.sub.1 and R.sub.2 is OH or OCH.sub.3. Compositions, useful for producing analgesia in humans or lower animals, comprise a safe and effective amount of: an alkadienamide, pharmaceutically-acceptable salts thereof, or mixtures thereof; and a pharmaceutically-acceptable carrier. Preferably, these alkadienamides are N-vanillyl-alkadienamides. Methods of treatment, comprising administering a safe and effective amount of these alkadienamides, pharmaceutically-acceptable salts thereof, or mixtures thereof, include methods of parenteral, oral, and topical administration.
烯二酰胺化合物及其药学上可接受的盐,其化学式为:##STR1## 其中X为O或S;R为直链或支链的二烯,其碳原子数为11至23个;R.sub.1为H、OH或OCH.sub.3;R.sub.2为OH或短链酯;并且R.sub.1和R.sub.2中至少有一个为OH或OCH.sub.3。用于在人类或低等动物中产生止痛作用的组合物包括:一种烯二酰胺、其药学上可接受的盐或其混合物;以及药学上可接受的载体。最好是这些烯二酰胺是N-香草基烯二酰胺。治疗方法包括经皮、口服和局部给药的方法,其中包括给予安全有效量的这些烯二酰胺、其药学上可接受的盐或其混合物。